Zdrowie i gospodarka · 14/12/2017

Patient-Focused Drug Development: Developing and Submitting Proposed Draft Guidance Relating to Patient Experience Data

The Food and Drug Administration (FDA) is hosting a public workshop to discuss how to develop and submit proposed draft guidance on patient experience data for consideration by the agency. The workshop aims to inform the development of patient-focused drug development guidance as required by the 21st Century Cures Act.